Development of a Polyelectrolyte Complex Scaffold and its specific cell seeding method as a tool for liquid cancers drug screening
Simon GrossemyiD, Sarah CadotiD, Maylis FarnoiD, Sandrine CavaliéiD, B Sallerin, Loïc YsebaertiD, Anne Quillet‐MaryiD, Sophie Girod FullanaiD
Abstract
This study focuses on the development of 3D culture model dedicated to liquid cancers drug screening. The challenge addressed was to effectively retain non adherent small cells within a 3D-scaffold with tailorable mechanical properties, while proposing a fast and effective tool for drug screening. To that aim, we developed a macroporous alginate-chitosan polyelectrolyte complex (PEC) scaffold combined with a low-viscosity alginate (LVA) cell seeding solution. We hypothesized that LVA could undergo in situ pore gelation via calcium ions retained from the PEC fabrication process, enabling effective retention and homogeneous cell distribution, leading to an improved platform for drug screening and personalized medicine. First, we evaluated scaffold suitability for LVA infiltration and gelation. Microtomography revealed a highly porous architecture (98%) enabling LVA homogeneous penetration and complete gelation within 30 min, as confirmed by SEM, microscopy, rheology, and micro-rheology. Next, we assessed cell retention and biocompatibility using primary human chronic lymphocytic leukemia (CLL) cells. LVA-assisted seeding increased cell density 2.6-fold compared to medium alone, with homogeneous distribution, >80% viability over 7 days, and preserved differentiation into nurse-like cells. Finally, we demonstrated a proof of concept for drug screening. The Alginate-PEC scaffold (A-PEC scaffold) supported both qualitative live/dead imaging and rapid quantitative viability measurement with the Alamar Blue assay. Drug responses reproduced microenvironment-dependent protection effects observed in vivo. This integrated scaffold and seeding method provides a promising 3D platform for in vitro liquid cancer studies and drug screening on patient-derived hematological cancer cells. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=67 SRC="FIGDIR/small/722037v1_ufig1.gif" ALT="Figure 1"> View larger version (38K): org.highwire.dtl.DTLVardef@9b71d4org.highwire.dtl.DTLVardef@14e1dd0org.highwire.dtl.DTLVardef@1876a56org.highwire.dtl.DTLVardef@15656bc_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Engineering High Throughput Screening Platforms of Cervical Cancer
I. A. Cadena, M. R. Buchanan, … K. C. Fogg·bioRxiv·Oct 16, 2022
- Engineering a three-dimensional multilayer multicellular model of endometrial cancer for high throughput drug screening and novel treatment methods
I. A. Cadena, Claire E. Rowlands, … Kaitlin C. Fogg·bioRxiv·Feb 20, 2024
- 3D Printed Bioelectronic Scaffolds for Impedance-based Cytotoxicity Monitoring of In Vitro Cancer Models
Somtochukwu S. Okafor, Sandra K. Montgomery, … Alexandra L. Rutz·bioRxiv·May 12, 2026
- Nanoporous PEGDA ink for High-Resolution Additive Manufacturing of Scaffolds for Organ-on-a-Chip
V. Karamzadeh, M. Shen, … D. Juncker·bioRxiv·Nov 27, 2023
- A Bioinert Hydrogel Framework for Precision 3D Cell Cultures: Advancing Automated High-Content and High-Throughput Drug Screening
Hyunsu Jeon, Tiago Thomaz Migliati Zanon, … Yichun Wang·Small SciencePeer-reviewed·Feb 10, 2025
- A 2-Compartment Bone Tumor Model for Testing the Efficacy of Cancer Drugs
A. Komez, A. Buyuksungur, … V. Hasirci·bioRxiv·Nov 4, 2019